In vitro magnetic actuation of the Cellbots in a microfluidic channel. a)...
In vitro magnetic actuation of the Cellbots in a microfluidic channel. a) Fabricated microfluidic channel with loading chamber, micro-pillars, and tortuous route. b) Rolling motion of the Cellbots under a rotating magnetic field (scale bar = 50 μm). c) Magnetic pulling motion of the Cellbots under a magnetic field gradient (scale bar = 50 μm). d) Co-cultivation of the Cellbots with 2D attached hNTSCs in the microfluidic channel (scale bar =500 μm). DIV, days in vitro.

Source: DGIST

Intra-nasal administration

Microrobots for treating neurological diseases

The joint research team of Prof. Hongsoo Choi (DGIST) & Prof. Sung Won Kim (Seoul St. Mary’s Hospital), developed an hNTSC-based microrobot for minimally invasive delivery into the brain tissue via the intranasal pathway.

The team developed a magnetically powered human nuclear transfer stem cells(hNTSC)-based microrobot and a method of minimally invasive delivery of therapeutic agents into the brain via the intranasal pathway. And they also accomplished transplanting the developed stem cell-based microrobot into brain tissue through the intranasal pathway that bypasses the blood-brain barrier. The proposed method is superior in efficacy and safety compared to the conventional surgical method and is expected to bring new possibilities of treating various intractable neurological diseases such as Alzheimer's disease, Parkinson's disease, and brain tumors, in the future.

The limitation of stem cell therapy is the difficulty in delivering an exact amount of stem cells to an accurate targeted location deep in the body where the treatment is at high risk. Another limitation is that both efficacy and safety of the treatment are low owing to a large amount of the therapeutic agent loss during delivery, while the cost of the treatment is high. In particular, when delivering stem cells into the brain through blood, the efficiency of cell delivery may decrease owing to the “blood-brain barrier,” which is a unique and specific component of the cerebrovascular network.

To overcome these limitations, the joint research team at DGIST and Seoul St., Mary’s Hospital of the Catholic University developed a magnetically powered hNTSC-based microrobot that can be freely and reliably be manipulated within the human body using an external magnetic field. In the research, the team developed a microrobot by internalizing iron oxide nanoparticles with high biocompatibility and superparamagnetism into stem cells extracted from human nasal turbinate

The newly developed microrobot can perform rolling motion by an externally-controlled rotating magnetic field and translational motion by a magnetic field gradient, enabling efficient transport in various physiological environments in vivo. Therefore, with the application of an external magnetic field, the microrobot can be remotely controlled within the microfluidic channel, facilitating quick and accurate delivery to the target point.

The research team further verified that the newly developed microrobot was reliably transplanted to the brain tissue. In particular, the team injected the developed microrobot via the intranasal passage that bypassed the blood-brain barrier of mice, for the first time in the world, and moved the microrobot within the brain tissue using an external magnetic field for precise delivery to the cerebral cortex, accomplishing a successful transplant.

Prof. Choi commented, “This research overcomes the limitations in the delivery of a therapeutic agent into brain tissues owing to the blood-brain barrier.” He added, "It opens new possibilities for the treatment of various intractable neurological diseases, such as Alzheimer's disease, Parkinson's disease, and brain tumors, by enabling accurate and safe targeted delivery of stem cells through the movement of a magnetically powered hNTSC-based microrobot via the intranasal pathway.

Source: Daegu Gyeongbuk Institute of Science and Technology


Read all latest stories

Related articles


Battle for the brain

New Alzheimer's treatment approach targets tau

A new idea for treating Alzheimer’s disease could eradicate the toxic proteins most closely linked to cognitive decline in the places where they do the most damage, a study from researchers at…


Enhanced therapeutic delivery

Focused ultrasound shows promise for Alzheimer's treatment support

A recent preclinical study from scientists at Sunnybrook Research Institute, Canadian Blood Services and the University of Toronto has demonstrated that focused ultrasound improves the delivery of…


Bioengineered Neuronal Organoids

Generation of human brain organoids with the ability to learn

Scientists combined induced pluripotent stem cells (iPSC) and their deep knowledge in the bioengineering of human organoids to for the first time bioengineer the human brain at the macroscale level…

Related products

KABE Labortechnik – Consumables for pathology / histology

Histology Equipment

KABE Labortechnik – Consumables for pathology / histology

mediaire – mdbrain

Artificial Intelligence

mediaire – mdbrain

mediaire GmbH
Sarstedt – CSF false-bottom tube

CSF and Alzheimer’s Disease Diagnostics

Sarstedt – CSF false-bottom tube

Siemens Healthineers - Corindus CorPath GRX

Accessories / Complementary Systems

Siemens Healthineers - Corindus CorPath GRX

Siemens Healthineers